Notice of Results
Updated : 07:12
Intelligent Ultrasound Group plc
("the Company")
Notice of Results
Analyst briefing
Intelligent Ultrasound Group plc (LSE: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its interim results for the six months ended 30 June 2020 on Thursday, 6 August 2020.
The Company will host a briefing for analysts via ZOOM at 9.30am on Thursday, 6 August. If you would like to register to dial in to the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email intelligentultrasound@walbrookpr.com.
For further information, please contact:
Intelligent Ultrasound Group plc | www. intelligentultrasound.com | ||||
Stuart Gall, CEO | Tel: +44 (0)29 2075 6534 | ||||
Cenkos Securities - Nominated Advisor and Broker | Tel: +44 (0)20 7397 8900 | ||||
Giles Balleny / Cameron MacRitchie (Corporate Finance) | |||||
Michael Johnson / Julian Morse (Sales) | |||||
Walbrook PR | Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com | ||||
Anna Dunphy / Paul McManus | Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893 | ||||
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market.
Based in Cardiff and Oxford in the UK, Atlanta in the US and with representation in Beijing in Asia, the Group operates two divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of protocol-based ultrasound scanning; and AnatomyGuide, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based needle guidance software for a range of medical procedures.
Simulation Division
Focusses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date over 800 simulators have been sold to almost 500 medical institutions around the world.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.